Common Variation at SLC16A11 and Other Genes on the Response to a Mixed Meal Tolerance Test
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to examine whether specific genes (e.g. SLC16A11)
affect how human beings respond to food and a medication that is commonly used to treat type
2 diabetes. The food the investigators will be studying is specially prepared to contain
protein, carbohydrate, and fat. The drug the investigators are studying is metformin. The
investigators hypothesize that physiological responses to the meal and to the medication will
differ between carriers and non-carriers of genes associated with type 2 diabetes.